83
Views
10
CrossRef citations to date
0
Altmetric
Miscellaneous

Synthetic polymer systems in drug delivery

Pages 345-363 | Published online: 24 Feb 2005

Bibliography

  • Technical literature. MacroMed Incorporated, Utah, USA (September 2000).
  • KUMAR MNVR, KUMAR N: Polymeric controlled drug-delivery systems: perspective issues and opportunities. Drug Dev. Ind. Pharm. (2001) 27:1–30.
  • KUMAR MNVR: Nano and microparticles as controlled drug delivery devices. J. Pharm. Pharm. Sci. (2000) 3:234–258.
  • BROUWERS JRBJ: Advanced and controlled drug delivery systems in clinical disease management. Pharm. World Sci. (1996) 18:153–162.
  • HELLER J: Polymers for controlled parenteral delivery of peptides and proteins. Adv. Drug Deliver. Rev. (1993) 10:163–204.
  • PEPPAS NA: Hydrogels and drug delivery. Curr. Opin. Coil. Int. Sci. (1997) 2:531–537.
  • •A useful overview of the types of polymer hydrogel currently being evaluated for controlled release.
  • PEPPAS NA, BURES P, LEOBANDUNG W, ICHIKAWA H: Hydrogels in pharmaceutical formulations. Eur. J. Pharm. Biopharm. (2000) 50:27–46.
  • •A review covering many aspects of drug delivery, including a discussion of the kinetics of release from complex polymer matrices.
  • KAMATH KR, PARK K: Biodegradable hydrogels in drug-delivery. Adv. Drug Deliver. Rev. (1993) 11: 59–84.
  • DUNCAN R: Polymer-drug conjugates, PDEPT and PELT: a novel anticancer approach. Clin. Cancer Res. (2000) 6(Suppl.):13.
  • GIANASI E, WASIL M, EVAGOROU EG et al.: HPMA copolymer platinates as novel antitumour agents: in vitro properties, pharmacokinetics and antitumour activity in vivo. Eur. j Cancer (1999) 35:994–1002.
  • DUNCAN R: Polymer therapeutics for tumour specific delivery. Chem. Ind. (London) (1997):262–264.
  • MATSUMURA Y, MAEDA H: A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the anti-tumour agent SMANCS. Cancer Res. (1986) 46:6387–6392.
  • •The first account of the enhanced permeation and retention (EPR) effect in anticancer therapy.
  • DUNCAN R: Polymer conjugates for tumour targeting and intracytoplasmic delivery. The EPR effect as a common gateway? Pharm. Sci. TechnoL Today (1999) 2:441–449.
  • •A review covering the chemistry and biological action of polymer therapeutics.
  • KOPECEK J, KOPECKOVA P, MINKO T et al.: HPMA copolymer-anticancer drug conjugates: design, activity, and mechanism of action. Eur. j Pharm. Biopharm. (2000) 50:61–81.
  • •Primary paper on the effect of antineoplastics bound to biocompatible polymers via enzyme-degradable linkers.
  • OMELYANENKO V, KOPECKOVA P, GENTRY C et al.: Targetable HPMA copolymer-adriamycin conjugates. Recognition, internalization, and subcellular fate. J. Control. Rel. (1998) 53:25–37.
  • SHIAH JG, DVORAK M, KOPECKOVA P et al.: Biodistribution and antitumour efficacy of long-circulating N-(2-hydroxypropypmethacrylamide copolymer-doxorubicin conjugates in nude mice. Eur. J. Cancer (2001) 37:131–139.
  • SHIAH JG, SUN YG, PETERSON CM et al.: Biodistribution of free and N-(2-hydroxypropypmethacrylamide copolymer-bound mesochlorine(6) and adriamycin in nude mice bearing human ovarian carcinoma OVCAR-3 xenografts.j Control. Rel. (1999) 61:145–157.
  • •A detailed account of the fate of polymer therapeutics following degradation in vivo.
  • ORLOWSKI S,GARRIGOS M: Multiple recognition of various amphiphilic molecules by the multi-drug resistance P-glycoprotein: molecular mechanisms and pharmacological consequences coming from functional interactions between various drugs. Anti-Cancer Res. (1999) 19: 3109–3123.
  • GERMANN UA, CHAMBERS TC: Molecular analysis of the multi-drug transporter, P-glycoprotein. Cytotechnology (1998) 27:31–60.
  • VASEY PA, KAYE SB, MORRISON R et al.: Phase I clinical and pharmacokinetic study of PK1 [N-(2-hydroxypropyl) methacrylamide copolymer doxorubicin]: first member of a new class of chemotherapeutic agents - drug-polymer conjugates. Clin. Cancer Res. (1999) 5:83–94.
  • •• The first polymer therapeutics to undergo clinical trials.
  • VOGTLE F, GESTERMANN S, HESSE R et al.: Functional dendrimers. Prog. Polym. Sci. (2000) 25:987–1041.
  • •A detailed review of dendrimer science from chemistry through materials science to biology.
  • TWYMAN LJ, BEEZER AE, ESFAND R et al.: The synthesis of water soluble dendrimers, and their application as possible drug delivery systems. Tetrahedron Lett. (1999) 40:1743–1746.
  • WANG D, KOPECKOVA P, MINKO T et al.: Synthesis of starlike N-(2-hydroxypropypmethacrylamide copolymers: potential drug carriers. Biomacromolecules (2000) 1:313–319.
  • WIWATTANAPATAPEE R, CARRENO-GOMEZ B, MALIK N et al.: Anionic PAMAM dendrimers rapidly cross adult rat intestine in vitro: a potential oral delivery system? Pharmaceut. Res. (2000) 17:991–998.
  • BOAS U, KARLSSON AJ, DE WAAL BFM et al.: Synthesis and properties of new thiourea-functionalized poly(propylene imine) dendrimers and their role as hosts for urea functionalized guests. J. Org. Chem. (2001) 66:2136–2145.
  • PISTOLIS G, MALLIARIS A, TSIOURVAS D et al.: Poly(propyleneimine) dendrimers as pH-sensitive controlled-release systems. Chem. Eur. J. (1999) 5:1440–1444.
  • LI M, KONO K, FRECHET JMJ: Water-soluble dendritic unimolecular micelles: their potential as drug delivery agents. J. Control. Rel. (2000) 65:121–131.
  • ••The synthesis and characterisation of PEG-tipped dendrimers, and release profile of entrapped indomethacin.
  • BIELINSKA AU, YEN A, WU HL et al.: Application of membrane-based dendrimer/ DNA complexes for solid phase transfection in vitro and in vivo. BiomateriaLs (2000) 21:877–887.
  • MALIK N, WIWATTANAPATAPEE R, KLOPSCH et al.: Dendrimers: relationship between structure and biocompatibility in vitro and preliminary studies on the biodistribution of 125I-labelled polyamidoamine dendrimers in vivo. J. Control. Rel. (2000) 65:133–148.
  • KOST J, LANGER R: Responsive polymeric delivery systems. Adv. Drug Deliver. Rev. (2000) 46:125–148.
  • GALAEV IY, MATTIASSON B: Smart polymers and what they could do in biotechnology and medicine. Trends Biotechnol.(1999) 17:335–340.
  • •A useful review covering a number of aspects relating to responsive polymers.
  • HOFFMAN AS, STAYTON PS, BULMUS V et al.: Really smart bioconjugates of smart polymers and receptor proteins./ Biomed. Mater. Res. (2000) 52:577–586.
  • HESKINS M, GUILLET JE: Solution properties of poly (NIPAAm).J. Macromol. Sci. Chem. (1968) A2:1441.
  • •The first detailed account of the phase transition properties of poly(N-isopropylacrylamide).
  • SCHILD HG: Poly (N-isopropylacryl amide) - experiment, theory and application. Prog Polym. Sci. (1992) 17:163–249.
  • ••Comprehensive review of poly(N-isopropylacrylamide) chemistry and properties.
  • FEIL H, BAE YH, JAN FJ et al.: Effect of comonomer hydrophilicity and ionization on the lower critical solution temperature of N-isopropylacrylamide copolymers. Macromolecules (1993) 26:2496–2500.
  • DAUTZENBERG H, GAO Y, HAHN M: Formation, structure, and temperature behaviour of polyelectrolyte complexes between ionically modified thermosensitive polymers. Langmuir (2000) 16:9070–9081
  • HOFFMAN AS: Environmentally sensitive polymers and hydrogels. MRS Bulletin (1991) 16:42–46.
  • ROSEN O, SJOSTROM J, PICULELL L: Responsive polymer gels based on hydrophobically modified cellulose ethers and their interactions with ionic surfactants. Langmuir (1998) 14:5795–5801.
  • HOFFMAN AS: Applications of thermally reversible polymers and hydrogels in therapeutics and diagnostics./ Control. Rel. (1987) 6:297–305.
  • CHEN GH, HOFFMAN AS: Graft copolymers that exhibit temperature induced phase transitions over a wide range of pH. Nature (1995) 373:49–52.
  • ••Side chain grafts of temperature sensitivepolymers to a pH responsive polymer backbone enabling the switching of the copolymers under a variety of conditions.
  • STAYTON PS, SHIMOBOJI T, LONG C, CHILKOTI A et al.: Control of protein-ligand recognition using a stimuli- responsive polymer. Nature (1995) 378:472–474.
  • ••The first example of reaction chemistrycontrol by grafting a thermoresponsive polymer to an engineered streptavidin mutant allowing the on/off switching of the protein binding site.
  • BAE YH, OKANO T, HSU R, KIM SW: Thermosensitive polymers as on-off switches for drug release. Makromol. Chem. Rapid Commun. (1987) 8:481–485.
  • AMENDE T, NIKOS AG: Diffusion controlled delivery of proteins from hydrogels and other hydrophilic systems. In: Protein Delivery: Physical Systems. Sanders LM, Hendren RW (Eds.), Plenum Press, Tokyo, Japan (1997):139–165.
  • CANAL T, PEPPAS NA: Correlation between mesh size and equilibrium degree of swelling of polymeric network. J. Thorned. Mater. Res. (1989) 23:1183–1193.
  • COLOMBO P, PEPPAS NA: Analysis of drug release behaviour from swellable polymer carriers using the dimensionality index. J. Control. Rel. (1997) 45: 221–227.
  • NARASIMHAN B, PEPPAS NA: Molecular analysis of drug delivery systems controlled by dissolution of the polymer carrier. J. Pharm. Sci. (1997) 86:297–304.
  • OKAHATA Y, NOGUCHI H, SEKI T: Functional capsule membranes 23. Thermoresponsive permeation from a polymer grafted capsule membrane. Macromolecules (1986) 19:493–494.
  • YOSHIDA R, UCHIDA K, KANEKO Y et al.: Comb-type grafted hydrogels with rapid de-swelling response to temperature-changes. Nature (1995) 374:240–242.
  • •A novel mechanism of hydrogel collapse where pendent linear and flexible PNIPAm chains 'catalyse' the de-swelling of a more constrained cross-linked PNIPAm matrix.
  • DINARVAND R, D'EMANUELE A: The use of thermoresponsive hydrogels for on-off release of molecules. J. Control. Rel. (1995) 36:221–227.
  • •The first description of the use of responsive polymers as valve-based drug release devices.
  • BRONDSTED H, KOPECEK J: pH sensitive hydrogels: characteristics and potential in drug delivery. In: Polyelectrolyte Gels. Harland RS, Prud'homme RK (Eds.), ACS Symp. Series (1992) 480:1.
  • KOU JH, AMIDON GL, LEE PI: pH-Dependent swelling and solute diffusion characteristics of poly(hydroxyethylmeth acrylate-co-methacrylic acid) hydrogels. Pharm. Res. 5:592–597.
  • BRANNONPEPPAS L, PEPPAS NA: Equilibrium swelling behaviour of dilute ionic hydrogels in electrolytic solutions. J. Control. Rel. (1991) 16:319–330.
  • NAKAMURA K, MAITANIY, LOWMAN AM et al.: Uptake and release of budesonide from mucoadhesive, pH-sensitive polymers and their application to nasal delivery. J. Control. Rel. (1999) 61:329–335.
  • •A detailed account of the release profiles of a therapeutic from an acid-sensitive polymer gel.
  • AIKAWA K, MITSUTAKE N, UDA H et al.: Drug release from pH-response polyvinylacetaldimethylaminoacetate hydrogel, and application to nasal delivery. Int. J.Pharm. (1998) 168:181–188.
  • VAKKALANKA SK, BRAZEL CS, PEPPAS NA: Temperature and pH-sensitive terpolymers for modulated delivery of streptokinase. J. Monied. Mater. Sci. Polym. Ed. (1996) 8:119–129.
  • SERRES A, BAUDYS M, KIM SW: Temperature and pH-sensitive polymers for human calcitonin delivery. Pharm. Res. (1996) 13:196–201.
  • BIGNOTTI F, PENCO M, SARTORE L et al.: Synthesis, characterisation and solution behaviour of thermo- and pH-responsive polymers bearing L-leucine residues in the side chains. Polymer (2000) 41:8247–8256.
  • •Biomimetic responsive polymers with chiral side chains.
  • KOST J, HORBETT TA, RATNER BD, SINGH M: Glucose sensitive membranes containing glucose oxidase: activity, swelling and permeability studies./ Biomed Mater. Res. 1985 19:1117–1133.
  • KOST J, LANGER R: Responsive polymersystems for controlled delivery of therapeutics. Trends Biotechnol. (1992) 10:127–131.
  • GOLDRAICH M, KOST J: Glucose-sensitive polymeric matrices for controlled drug delivery. Clin. Mater. (1993) 13:135–142.
  • TRAITEL T, COHEN Y, KOST J: Characterisation of glucose-sensitive insulin release systems in simulated in vivo conditions. BiomateriaLs (2000) 21:1679–1687.
  • •A detailed publication concerning the factors affecting insulin release from polymer gels containing immobilised glucose oxidase and catalase.
  • PODUAL K, DOYLE III FJ, PEPPAS NA: Preparation and dynamic response of cationic copolymer hydrogels containing glucose oxidase. Polymer (2000) 41:3975-3983.
  • Polyethylene Glycol Chemistry Harris JM (Ed.), Plenum Press, New York, USA (1992).
  • IMANISHI Y, ITO Y: Glucose-sensitive insulin-releasing molecular systems. Pure Appl. Chem. (1995) 67:2015–2021.
  • LEE SJ, PARK K: Synthesis and characterization of sol-gel phase-reversible hydrogels sensitive to glucose. J. Mal Recogn. (1997) 9:549–557.
  • OBAIDAT AA, PARK K: Characterization of protein release through glucose-sensitive hydrogel membranes. Biomaterials (1997) 18:801–806.
  • AOKI T, NISHIMURA T, SANUI K, OGATA N: Phase-transition changes of poly((N-(S)-sec-butlyacrylamide-co-N-isopropylacrylamide) in response to amino acids and its chiral recognition. React. Func. Polym. (1998) 37:299–303.
  • FUJIKI M: Helix magic. Thermo-driven chiroptical switching and screw-sense inversion of flexible rod helical polysilylenes. J. Am. Chem. Soc. (2000) 122:3336–3343.
  • YASHIMA E, MAEDA Y, OKAMOTO Y: Synthesis of poly[N-(4-ethynylbenzyl) ephedrine] and its use as a polymeric catalyst for enantioselective addition of dialkylzincs to benzaldehyde. Polym. J. (1999) 31\(Part 2):1033–1036.
  • YASHIMA E, MAEDA Y, OKAMOTO Y: Helix-helix transition of optically active poly((1R,2S)-N-(4-ethynylbenzyl) norephedrine) induced by diastereomeric acid-base complexation using chiral stimuli. J. Am. Chem. Soc. (1998) 120:8895–8896.
  • PARK K, ROBINSON JR: Bioadhesive polymers as platforms for oral controlled drug delivery: method to study bioadhesion. Int. J. Pharm. (1984) 19:107–127.
  • •An early publication describing bioadhesive polymers.
  • SMART JD, KELLAWAY IW, WORTHINGTON HEC: An in vitro investigation of mucosa-adhesive materials for use in controlled drug delivery. J. Pharm. Pharnzacol (1984) 36:295–299.
  • •One of the first examples employing mucoadhesion as a method for controlled drug delivery.
  • LEHR C-M: From sticky stuff to sweet receptors - achievement, limits and novel approaches to bioadhesion. Eur. J. Drug Metab. Pharmacokinet. (1996) 21:397–405.
  • •A review considering the mechanisms of lectin-sugar interactions and their role as bioadhesive formulations.
  • PEPPAS NA, SAHLIN JJ: Hydrogels as mucoadhesive and bioadhesive materials: a review. Biomaterials (1996) 17:1553–1561.
  • •A useful overview of the different types of hydrogel being developed for drug delivery, and discussion of the mechanisms of bioadhesive-enhancement of drug targeting.
  • HUANG YB, LEOBANDUNG W, FOSS A et al.: Molecular aspects of muco- and bioadhesion: Tethered structures and site-specific surfaces. J. Control Rel. (2000) 65:63–71.
  • LEHR C-M: Lectin-mediated drug delivery. A second generation of bioadhesives. J. Control. Rel. (2000) 65:19–29.
  • •A paper describing cytoadhesive polymers as novel drug delivery vehicles, with particular emphasis on internalisation pathways of liposome-lectin conjugates.
  • EASSON JH, HALTNER E, LEHR C-M, JAHN D: Bacterial invasin factors and lectins as second generation bioadhesives. In: Bioadhesive Drug Delivery Systems - Fundamentals, Novel Approaches and Developments. Mathiowitz E, Chickering DE, Lehr C-M (Eds.), Marcel Dekker, New York, USA (1999):409–432.
  • DAVIS BG: Recent developments in glycoconjugates. J. Chem. Soc. Perkin Trans. 1 (1999):3215–3237.
  • ••A thorough review of the leadingdevelopments in synthetic glycoscience, detailing syntheses of sugar-containing polymers, glycoproteins and potential applications.
  • SHARON N, LIS H: Lectins - proteins with a sweet tooth: functions in cell recognition. Essays Biochem. (1995) 30:59–75.
  • MAMMEN M, CHOI SK, WHITESIDES GM: Polyvalent interactions in biological systems: implications for design and use of multivalent ligands and inhibitors. Angew Chem. Int. Ed. Engl (1998) 37(20):2755–2794.
  • ••An important account of the mechanismsof molecular recognition in biology and the preparation of synthetic receptors for mediating biorecognition.
  • CHOI SK, MAMMEN M, WHITESIDES GM: Generation and in situ evaluation of libraries of poly(acrylic acid) presenting sialosides as side chains as polyvalent inhibitors of influenza-mediated hemagglutination. J. Am. Chem. Soc. (1997) 119(18):4103–4111.
  • ••The synthesis of anti-influenzaglycopolymers by an elegant and facile pseudo-combinatorial route.
  • CHOI SK, LEE S, WHITESIDES GM: Synthesis of C-5 analogs of N-acetylneuraminic acid via indium-mediated allylation of N-substituted 2-amino-2-deoxymannoses. j Org. Chem. (1996) 61(25):8739–8745.
  • GORECKI D: Gene therapy: prospects and problems. Emerging Drugs (1999) 4:247–261.
  • •Review of the principal goals in gene therapy and possible obstacles to effective gene-based therapeutics.
  • KABANOV AV, KABANOV VA: DNA complexes with polycations for the delivery of genetic material into cells. Bioconj. Chem. (1995) 6:7–20.
  • FELGNER JH, KUMAR R, SRIDHAR CN et al.: Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations. J. Biol. Chem. (1994) 269:2550–2561.
  • WANG CY, HUANG L: Highly efficient DNA delivery mediated by pH-sensitive immunoliposomes. Biochemistry (1989) 28:9508–9514.
  • •Early example of the use of liposomes in DNA transfection.
  • OUPICKV D, KONAK C, ULBRICH K et al.: DNA delivery systems based on complexes of DNA with synthetic polycations and their copolymers. J. Control. Rel. (2000) 65:149–171.
  • ••A very detailed account of the synthesisand gene therapy applications of novel cationic copolymers.
  • VAN DE WETERING P, CHERNG J-Y, TALSMA H, CROMMELIN DJA, HENNINK WE: 2-(Dimethylamino)ethyl methacrylate based (co)polymers as gene transfer agents. J. Control. Rel. (1998) 53:145–153.
  • POUTON CW, SEYMOUR LW: Key issues in non-viral gene delivery. Adv. Drug Deliver. Rev. (2001) 46:187–203.
  • ••A comprehensive review of potential genetherapies.
  • ZABNER J, FASBENDER Al, MONINGER T, POELLINGER KA, WELSH MJ: Cellular and molecular barriers to gene transfer by a cationic lipid.J. Biol. Chem. (1995) 270:18997–19007.
  • XU Y, SZOKA F, JR.: Mechanism of DNArelease from cationic liposome/DNA complexes used in cell transfection. Biochemistry (1996) 35:5616–5623.
  • CAMILLERI P, KREMER A, EDWARDS AJ et al.: A novel class of cationic gemini surfactants showing efficient in vitro gene transfection properties. Chem. Commun. (2000):1253–1254.
  • POUTON CW, LUCAS P, THOMAS BJ et al.: Polycation-DNA complexes for gene delivery: a comparison of the biopharmaceutical properties of cationic polypeptides and cationic lipids. J. Control. Rel. (1998) 53:289–299.
  • THOMAS J, TIRRELL DA: Polyelectrolyte-sensitized phospholipid vesicles. Acc. Chem. Res. (1992) 25:336–342.
  • TOSTESON MT, HOLMES SJ, RAZIN M, TOSTESON DC: Mellitin lysis of red blood cells. J. Membrane Bia (1985) 87:35–44.
  • STAYTON PS, HOFFMAN AS, MURTHY N et al.: Molecular engineering of proteins and polymers for targeting and intracellular delivery of therapeutics. J Control. Rel. (2000) 65:203–220.
  • •The preparation of engineered streptavidin-RGD conjugates for cell-specific targeting and pH-sensitive polymer conjugates for membrane-disruption mediated DNA transfection.
  • HART SL, HARBOTTLE RP, COOPER R, MILLER A, WILLIAMSON R, COUTELLE C: Gene delivery and expression mediated by an integrin binding peptide. Gene Ther. (1996) 3:1032–1033.
  • HINRICHS Nnj, SCHUURMANS-NIEUWENBROEK NME, VAN DE WETERING P, HENNINK WE: Thermosensitive polymers as carriers for DNA delivery. J Control. Rel. (1999) 60:249–259.
  • ••Paper describing the role of phase-transition polymers as potential DNA-delivery agents, and characterisation of polymer-DNA conjugates in terms of particle size, zeta potential and transfection activity.
  • KURISAWA M, YOKOYAMA M, OKANO T: Transfection efficiency increases by incorporating hydrophobic monomer units into polymeric gene carriers. J Control. Rel. (2000) 68:1–8.
  • ••Demonstration of enhanced gene delivery by variation of copolymer structure to include a hydrophobic component, butyl methacrylate.
  • KURISAWA M, YOKOYAMA M, OKANO T: Gene expression controlled by temperature with thermo-sensitive polymeric gene carriers. J Control. Rel. (2000) 69:127–137.
  • •Preliminary account of DNA transfection mediated by responsive poly(N-isopropylacrylamide) copolymers.
  • GEORGES MK, VEREGIN RPN, HAMER GK, KAZMAIER PM: Breathing new life into the free-radical polymerization process. Macromol. Symp. (1994) 88:89–103.
  • PATTEN TE, MATYJASZEWSKI K: Atom transfer radical polymerization and the synthesis of polymeric materials. Adv. Mater. (1998) 10:901.
  • WANG X-S, ARMES SP: Facile polymerization of methoxy-capped oligo(ethylene glycol) methacrylate via atom transfer radical polymerisation in aqueous media at ambient temperature. Macromolecules (2000) 33:6640–6647
  • ANGOT S, AYRES N, BON SAF, HADDLETON DM: Living radical polymerization immobilized on wang resins: Synthesis and harvest of narrow polydispersity poly(methacrylate)s. Macromolecules (2001) 34:768–774.
  • BENOIT D, HARTH E, FOX P, WAYMOUTH RM, HAWKER CJ: Accurate structural control and block formation in the living polymerization of 1,3-dienes by nitroxide-mediated procedures. Macromolecules (2000) 33:363–370.
  • VLCEK P, LOCHMANN L: Anionic polymerization of (meth)acrylate esters in the presence of stabilizers of active centres. Prog. Polym. Sci. (1999) 24:793–873.
  • KUBISA P, PENCZEK S: Cationic activated monomer polymerization of heterocyclic monomers. Prog. Polym. Sci. (1999) 24:1409–1437.
  • BIAGINI SCG, DAVIES RG, GIBSON VC, GILES MR, MARSHALL EL, NORTH M: Ruthenium initiated ring opening metathesis polymerisation of amino-acid and -ester functionalised norbornenes and a highly selective chain-end functionalisation reaction using molecular oxygen. Polymer (2001) 42:6669–6671.
  • FEAST WJ, KHOSRAVI E: Synthesis of fluorinated polymers via ROMP: a review. J Fluor. Chem. (1999) 100:117–125.
  • ESFAND R, TOMALIA DA: Poly(amidoamine) (PAMAM) dendrimers: from biomimicry to drug delivery and biomedical applications. Drug Disc. Today (2001) 6:427–436.
  • ••The development of dendrimers astherapeutic agents, including a comparison of different structures ('generations') of dendrimer with important biomolecules and aggregates such as lipid bilayers and cellular membranes.
  • WU C: A comparison between the `coil-to-globule' transition of linear chains and the 'volume phase transition' of spherical microgels. Polymer (1998) 9:4609–4619.
  • HUVAL CC, BAILEY MJ, BRAUNLIN WH et al.: Novel cholesterol lowering polymeric drugs obtained by molecular imprinting. Macromolecules (2001) 34:1548–1550.
  • ASANUMA H, HISHIYA T, KOMIYAMA M: Tailor-made receptors by molecular imprinting. Adv Mater (2000) 12:1019–1030.
  • ALLENDER CJ, BRAIN KR, HEARD CM, PELLETT MA: Imprinted polymers, novel excipients in controlled delivery systems. Proc. Int. Symp. Controlled Release Bioact. Mater. (1997) 24:585–586.
  • WULFF G: Molecular imprinting in cross-linked materials with the aid of molecular templates - a way towards artificial antibodies. Angew. Chem., Intl. Ed. Engl. (1995) 34:1812–1832.
  • ••Comprehensive review of the preparationand applications of imprinted polymers.
  • WHITCOMBE MJ, ALEXANDER C, VULFSON EN: Imprinted polymers: Versatile new tools in synthesis. Synlett (2000):911–923.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.